Intrathoracic extensive-stage small cell lung cancer: assessment of the benefit of thoracic and brain radiotherapy using the SEER database

Omar Mahmoud, Deukwoo Kwon, Brad Greenfield, Jean Wright, Michael A. Samuels

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Extensive-stage small cell lung cancer (ESCLC) includes metastatic disease and locally advanced disease confined to the thorax that cannot be encompassed in a typical radiation portal. We assessed and then compared the benefits of thoracic radiotherapy (TRT) and/or brain radiotherapy (BRT) on overall survival (OS) between the intrathoracic (T-ESCLC) and metastatic (M-ESCLC) groups using the Surveillance Epidemiology and End Results database. Methods: TRT and BRT data were available for 10150 patients treated from 1988−1997. The T-ESCLC group included 1774 patients. The Kaplan–Meier method was used to estimate OS and the proportional hazards model was used to estimate OS hazard ratios for prognostic factors including age, gender, race, tumor size, T/N stage, TRT, and BRT. Results: The 2-year OS for T-ESCLC was 7.8 % compared to 3 % in the M-ESCLC group (p <0.001). In the T-ESCLC group, TRT and BRT were delivered to 750 and 102 patients, respectively. The 2-year OS was 13 % in the TRT group compared to 4.1 % in the no-TRT group (p ≤ 0.001) and 22.5 % in the BRT group compared to 7 % in the no-BRT group (p <0.001). In the M-ESCLC group, TRT and BRT were delivered to 3093 and 1887 patients, respectively. The 2-year OS was 4.4 % in the TRT group compared to 2.8 % in the no-TRT group (p <0.001) and 4.3 % in the BRT compared to 2.6 % in the no-BRT group (p <0.001). Age, gender, TRT and BRT were significant OS prognostic factors in both groups. Conclusions: Our study suggests that T-ESCLC is a disease entity distinct from M-ESCLC. Prospective studies to determine whether TRT should be recommended for the thoracic-only subgroup are warranted.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalInternational Journal of Clinical Oncology
DOIs
StateAccepted/In press - Jul 5 2016

Keywords

  • Brain radiotherapy
  • Intrathoracic extensive stage
  • Small cell lung cancer
  • Survival outcome
  • Thoracic radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Surgery
  • Hematology

Fingerprint Dive into the research topics of 'Intrathoracic extensive-stage small cell lung cancer: assessment of the benefit of thoracic and brain radiotherapy using the SEER database'. Together they form a unique fingerprint.

Cite this